The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
The post Enveda secures $311M to bring more nature-derived AI drugs into clinical trials appeared first on TechCrunch.
This session will explore how early-stage companies are building teams where humans and AI agents …
At TechCrunch Disrupt 2026, five sessions across the AI Stage and Real World AI Stage …
Potato farmers rub shoulders with rows of gleaming new data centres as Trump and Xi …